Clinical Trials on Hypotension, Orthostatic in New Zealand

Total 1040 results

James J. Peters Veterans Affairs Medical Center

Completed

Orthostatic Hypotension Among Veterans (OH)

Hypotension, Orthostatic Hypotension

United States
GlaxoSmithKline

Completed

Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives

Hypertension

United States
Hackensack Meridian Health

Withdrawn

Sinusoidal Galvanic Vestibular Stimulation for Neurogenic Orthostatic Hypotension / Syncope

Neurogenic Orthostatic Hypotension

United States
Chelsea Therapeutics
Chiltern International Inc.

Completed

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (NOH302)

Primary Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Symptomatic Neurogenic Orthostatic Hypotension (NOH) | Non-diabetic Neuropathy

United States, Australia, Canada, New Zealand
Theravance Biopharma

Terminated

Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure (OAK)

Symptomatic Neurogenic Orthostatic Hypotension

United States, Spain, Portugal, United Kingdom, France, Denmark, Ukraine, Israel, Estonia, Poland, Italy, Russian Federation, Australia, Austria, Bulgaria, Canada, Germany, New Zealand
Shire

Completed

Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension

Symptomatic Orthostatic Hypotension

United States, Poland, Czechia, Slovakia
Vanderbilt University Medical Center
NYU Langone Health

Completed

Norepinephrine Transporter Blockade, Autonomic Failure (NETAF) (NETAF)

Neurogenic Orthostatic Hypotension

United States
H. Lundbeck A/S

Completed

Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension (RESTORE)

Symptomatic Neurogenic Orthostatic Hypotension

United States
James J. Peters Veterans Affairs Medical Center
Kessler Foundation

Recruiting

Treatment of Orthostatic Hypotension in SCI (SCI)

Hypotension

United States
Hospital for Special Surgery, New York

Terminated

An Open Label Trial to Decrease Signs and Symptoms of Orthostatic Hypotension Using Midodrine or Intravenous Fluid Bolus in Patients Following Total Hip Arthroplasty

Orthostatic Hypotension

United States
Shire

Completed

Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension

Orthostatic Hypotension

United States
Theravance Biopharma

Completed

Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure (SEQUOIA)

Symptomatic Neurogenic Orthostatic Hypotension

United States, Spain, Israel, Hungary, Portugal, Australia, Canada, Germany, Russian Federation, Estonia, France, Italy, United Kingdom, Denmark, Poland, New Zealand, Austria, Bulgaria, Ukraine
Theravance Biopharma

Completed

TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)

Parkinson Disease | Orthostatic Hypotension | Neurogenic Orthostatic Hypotension | Hypotension, Orthostatic | Pure Autonomic Failure | Multiple System Atrophy (MSA) With Orthostatic Hypotension | Pure Autonomic Failure With Orthostatic Hypotension | Parkinson Disease With Orthostatic Hypotension

United States
National Center for Research Resources (NCRR)
Roberts Pharmaceutical

Completed

Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension

Orthostatic Hypotension

United States
Chelsea Therapeutics
Chiltern International Inc.

Completed

A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa (NOH301)

Primary Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Symptomatic Neurogenic Orthostatic Hypotension (NOH) | Non-diabetic Neuropathy

United States, Canada
Shire

Completed

A Study for Patients With Neurogenic Orthostatic Hypotension

Hypotension, Orthostatic

United States
Shire

Completed

Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension

Hypotension, Orthostatic

United States
James J. Peters Veterans Affairs Medical Center

Completed

Acetylcholinesterase Inhibition and Orthostatic Hypotension in SCI

Hypotension, Postural

United States
James J. Peters Veterans Affairs Medical Center

Completed

A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride

Orthostatic Hypotension | Spinal Cord Injury

United States
US Department of Veterans Affairs

Completed

A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury.

Spinal Cord Injuries | Orthostatic Hypotension

United States
US Department of Veterans Affairs

Completed

Safety and Efficacy of L-NAME and Midodrine to Increase MAP

Orthostatic Hypotension | Spinal Cord Injury

United States
Chelsea Therapeutics

Completed

Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (NOH303)

Multiple System Atrophy | Neurogenic Orthostatic Hypotension | Dopamine Beta Hydroxylase Deficiency | Non-Diabetic Autonomic Neuropathy

United States, Australia, Canada, New Zealand
Theravance Biopharma

Terminated

Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure (REDWOOD)

Parkinson's Disease (PD) | MSA | Symptomatic Neurogenic Orthostatic Hypotension | Pure Autonomic Failure (PAF)

United States, Spain, United Kingdom, Canada, France, Estonia, Australia, Israel, Denmark, Italy, Poland, New Zealand, Germany, Ukraine, Austria, Bulgaria, Portugal, Hungary, Russian Federation
James J. Peters Veterans Affairs Medical Center
Kessler Foundation; Seton Hall University

Unknown

RAAS and Arterial Stiffness in SCI

Hypotension | Orthostatic Hypotension | Spinal Cord Injury | Arterial Stiffness | Renin Angiotensin Aldosterone System

United States
Chelsea Therapeutics

Terminated

A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy

Parkinson's Disease | Pure Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Symptomatic Neurogenic Orthostatic Hypotension | Multiple Systems Atrophy

United States
Kessler Foundation

Recruiting

The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI) (SCI)

Cardiovascular Diseases | Central Nervous System Diseases | Nervous System Diseases | Trauma, Nervous System | Spinal Cord Diseases | Blood Pressure | Hypotension | Spinal Cord Injuries | Orthostatic Hypotension

United States
James J. Peters Veterans Affairs Medical Center

Recruiting

Autonomic Effects of Spinal Cord Stimulation in Spinal Cord Injury

Orthostatic Hypotension

United States
Kessler Foundation

Recruiting

Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI) (SCI)

Cardiovascular Diseases | Central Nervous System Diseases | Nervous System Diseases | Trauma, Nervous System | Spinal Cord Diseases | Blood Pressure | Hypotension | Spinal Cord Injuries | Orthostatic Hypotension | Acute Spinal Cord Injury

United States
James J. Peters Veterans Affairs Medical Center
Icahn School of Medicine at Mount Sinai

Completed

Treatment of Post-SCI Hypotension

Cerebral Blood Flow | Blood Pressure | Hypotension | Orthostatic Hypotension | Spinal Cord Injury | Autonomic Dysreflexia | Baroreceptor Integrity | Sympathetic Integrity | Vagal Integrity | Venous Occlusion Plethysmography

United States
Vanderbilt University Medical Center
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension (6103)

Parkinson's Disease | Multiple System Atrophy | Orthostatic Hypotension | Pure Autonomic Failure

United States
Theravance Biopharma

Recruiting

Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy (CYPRESS)

MSA - Multiple System Atrophy | Symptomatic Neurogenic Orthostatic Hypotension

United States, Spain, United Kingdom, Hungary, Italy, Argentina, Austria, Poland, Germany, Portugal, Belgium, Brazil, Denmark, Canada, France, Chile, Estonia
Icahn School of Medicine at Mount Sinai

Completed

Droxidopa in Treating Patients With Neurogenic Hypotension

Shy-Drager Syndrome | Orthostatic Hypotension

United States
James J. Peters Veterans Affairs Medical Center
New York State Department of Health

Completed

Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury

Hypotension | Spinal Cord Injuries | Hypotension, Orthostatic

United States
Chelsea Therapeutics

Completed

A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease (306A/306B)

Parkinson's Disease | Orthostatic Hypotension

United States
Capital Vision Research Trust

Completed

Optic Nerve Compliance Study

Glaucoma

New Zealand
Yale University

Completed

Racial Differences in Orthostatic Tolerance

Orthostatic Tolerance

United States
Medtronic Vascular

Completed

Multi-electrode Radiofrequency Renal Denervation System Feasibility Study

Uncontrolled Hypertension

Australia, New Zealand
NYU Langone Health

Recruiting

Natural History Study of Synucleinopathies

Parkinson Disease | Multiple System Atrophy | Neurogenic Orthostatic Hypotension | REM Sleep Behavior Disorder | Pure Autonomic Failure | Dementia With Lewy Bodies | Patients With Synucleinopathies | Shy-Drager Disease

Korea, Republic of, United States, Argentina, Spain
PolyActiva Pty Ltd

Completed

Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension.

Ocular Hypertension | Open Angle Glaucoma

New Zealand
Jonathann Kuo, MD

Active, not recruiting

Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID (DSBLongCOVID)

SARS-CoV2 Infection | Post-COVID-19 Syndrome | Dysautonomia | Post Acute COVID-19 Syndrome | Long COVID | Long Covid19 | COVID-19 Recurrent | Post-Acute COVID-19 | Post-Acute COVID-19 Infection | Post Acute Sequelae of COVID-19 | Dysautonomia Like Disorder | Dysautonomia Orthostatic Hypotension Syndrome | Post... and other conditions

United States
Kona Medical Inc.

Completed

Renal Denervation Using Externally Focused Therapeutic Ultrasound

Hypertension

Czech Republic, New Zealand
University of Reading
Massey University

Completed

The Effect of Olive Leaf Extract on Blood Pressure in Overweight Prehypertensives

Hypertension

New Zealand
RWTH Aachen University

Completed

Improved Orthostatic Tolerance = Better Cognitive Function in Parkinson's Disease (PaKogOH)

Parkinson Disease | Cognitive Impairment | Hypotension, Orthostatic | Autonomic Failure

Germany
New York Medical College
National Institutes of Health (NIH)

Completed

Cardiovagal Baroreflex Deficits Impair Neurovascular Coupling and Cognition in POTS

Orthostatic Intolerance | Postural Orthostatic Tachycardia Syndrome (POTS) | POTS

United States
Biosense Webster, Inc.

Completed

RENABLATE-II Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension - 157 (RENABLATE-II)

Hypertension, Renal

Czech Republic, Italy, New Zealand, Spain
NYU Langone Health

Completed

Accuracy of Non-invasive Non-oscillometric Blood Pressure Wristband

Hypertension | Hypotension

United States
State University of New York - Downstate Medical...

Terminated

ACEI/ARB Study in Ambulatory and Day of Surgery Admission Patients (ACE/ARB)

Hypertension | Hypotension

United States
Abbott Medical Devices

Completed

International First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled Hypertension (EnligHTN III)

Hypertension | Renal Denervation

New Zealand, Australia
New York Medical College

Completed

Local Vasoconstriction in Postural Tachycardia Syndrome

Postural Tachycardia Syndrome

United States
Yale University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Sex Hormones and Orthostatic Tolerance

Orthostatic Intolerance

United States

Clinical Trials on Hypotension, Orthostatic in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations